Annual CFF
$241.90 K
-$17.31 M-98.62%
31 December 2022
Summary:
Scopus BioPharma annual cash flow from financing activities is currently $241.90 thousand, with the most recent change of -$17.31 million (-98.62%) on 31 December 2022. During the last 3 years, it has fallen by -$4.11 million (-94.44%). SCPS annual CFF is now -98.62% below its all-time high of $17.56 million, reached on 31 December 2021.SCPS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$44.70 K
-$2.06 M-102.21%
30 June 2023
Summary:
Scopus BioPharma quarterly cash flow from financing activities is currently -$44.70 thousand, with the most recent change of -$2.06 million (-102.21%) on 30 June 2023. SCPS quarterly CFF is now -100.49% below its all-time high of $9.20 million, reached on 31 March 2021.SCPS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.22 M
-$44.70 K-1.98%
30 June 2023
Summary:
Scopus BioPharma TTM cash flow from financing activities is currently $2.22 million, with the most recent change of -$44.70 thousand (-1.98%) on 30 June 2023. SCPS TTM CFF is now -87.37% below its all-time high of $17.56 million, reached on 31 December 2021.SCPS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -94.4% | +57.2% | -80.6% |
| 5 y5 years | -59.5% | -111.4% | +1.4% |
SCPS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.6% | at low | -100.5% | +57.2% | -87.4% | +816.3% |
| 5 y | 5 years | -98.6% | at low | -100.5% | +57.2% | -87.4% | +816.3% |
| alltime | all time | -98.6% | at low | -100.5% | +57.2% | -87.4% | +1113.3% |
Scopus BioPharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$44.70 K(-102.2%) | $2.22 M(-2.0%) |
| Mar 2023 | - | $2.02 M(+734.8%) | $2.26 M(+834.8%) |
| Dec 2022 | $241.90 K(-98.6%) | $241.90 K(>+9900.0%) | $241.90 K(-97.1%) |
| Sept 2022 | - | $0.00(0.0%) | $8.48 M(+1.2%) |
| June 2022 | - | $0.00(0.0%) | $8.38 M(+0.2%) |
| Mar 2022 | - | $0.00(-100.0%) | $8.36 M(-52.4%) |
| Dec 2021 | $17.56 M(+303.4%) | $8.48 M(-8215.0%) | $17.56 M(+53.5%) |
| Sept 2021 | - | -$104.50 K(+447.1%) | $11.44 M(-3.7%) |
| June 2021 | - | -$19.10 K(-100.2%) | $11.87 M(-11.9%) |
| Mar 2021 | - | $9.20 M(+289.7%) | $13.47 M(+209.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $4.35 M(+99.3%) | $2.36 M(+611.6%) | $4.35 M(+118.9%) |
| Sept 2020 | - | $331.80 K(-79.0%) | $1.99 M(-2.9%) |
| June 2020 | - | $1.58 M(+1854.2%) | $2.05 M(+43.3%) |
| Mar 2020 | - | $80.80 K(-2793.3%) | $1.43 M(-34.5%) |
| Dec 2019 | $2.18 M(+265.4%) | -$3000.00(-100.8%) | $2.18 M(-0.1%) |
| Sept 2019 | - | $392.20 K(-59.1%) | $2.19 M(+21.9%) |
| June 2019 | - | $959.50 K(+14.9%) | $1.79 M(+115.0%) |
| Mar 2019 | - | $835.00 K(<-9900.0%) | $834.50 K(+356.8%) |
| Dec 2018 | $597.60 K | - | - |
| June 2018 | - | -$500.00(-100.3%) | $182.70 K(-0.3%) |
| Mar 2018 | - | $183.20 K | $183.20 K |
FAQ
- What is Scopus BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for Scopus BioPharma?
- What is Scopus BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Scopus BioPharma?
- What is Scopus BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Scopus BioPharma?
What is Scopus BioPharma annual cash flow from financing activities?
The current annual CFF of SCPS is $241.90 K
What is the all time high annual CFF for Scopus BioPharma?
Scopus BioPharma all-time high annual cash flow from financing activities is $17.56 M
What is Scopus BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of SCPS is -$44.70 K
What is the all time high quarterly CFF for Scopus BioPharma?
Scopus BioPharma all-time high quarterly cash flow from financing activities is $9.20 M
What is Scopus BioPharma TTM cash flow from financing activities?
The current TTM CFF of SCPS is $2.22 M
What is the all time high TTM CFF for Scopus BioPharma?
Scopus BioPharma all-time high TTM cash flow from financing activities is $17.56 M